开发膝关节置换术的个性化结局预测工具
本研究前瞻性收集2015年7月至2018年6月接受全膝或单髁膝关节置换术患者数据,队列1(n=5,958)用于开发住院时长和90天再入院模型,队列2(n=2,391)用于开发一年KOOS疼痛、功能和生活质量改善模型,数据驱动模型可准确估计改善概率及住院时长和再入院风险。
要点
- 住院时长模型交叉验证RMSE为1.161,预测新患者数据集准确率71.5%。
- 90天再入院模型在新患者数据集验证AUC对应准确率65.0%。
- 一年KOOS疼痛、功能、生活质量改善模型预测10分改善的准确率分别为72.1%、72.9%、70.8%。
核心结论
- 本研究开发的数据驱动模型提供了可扩展的预测工具,能准确估计膝关节置换术后一年疼痛、功能和生活质量改善的可能性以及住院时长和90天再入院风险。
研究设计与样本
- 前瞻性收集2015年7月至2018年6月期间所有接受全膝或单髁膝关节置换术患者的数据。
- 队列1(n=5,958)用于开发住院时长和90天再入院模型。
- 队列2(n=2,391,手术日期2015至2017年)用于开发一年KOOS疼痛、功能和生活质量评分改善模型。
主要发现
- 在插补数据集内,住院时长模型RMSE为1.161,KOOS疼痛、功能和生活质量模型的RMSE分别为15.775、11.056、21.680。
- 在新患者数据集验证中,住院时长和再入院模型的准确率分别为71.5%和65.0%。
- 一年KOOS疼痛、功能和生活质量改善模型预测10分改善的准确率分别为72.1%、72.9%和70.8%。
- 所有模型在新患者数据集中的预测准确率总体与交叉验证准确率一致。
关键数值与推荐
- 住院时长模型交叉验证RMSE为1.161。
- KOOS疼痛、功能和生活质量模型的RMSE分别为15.775、11.056、21.680。
- 住院时长和再入院模型在新患者数据集验证的准确率分别为71.5%和65.0%。
- 一年KOOS疼痛、功能和生活质量改善模型预测10分改善的准确率分别为72.1%、72.9%和70.8%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The purpose of this study was to develop a personalized outcome prediction tool, to be used with knee arthroplasty patients, that predicts outcomes (lengths of stay (LOS), 90 day readmission, and one-year patient-reported outcome measures (PROMs) on an individual basis and allows for dynamic modifiable risk factors. METHODS: Data were prospectively collected on all patients who underwent total or unicompartmental knee arthroplasty at a between July 2015 and June 2018. Cohort 1 (n = 5,958) was utilized to develop models for LOS and 90 day readmission. Cohort 2 (n = 2,391, surgery date 2015 to 2017) was utilized to develop models for one-year improvements in Knee Injury and Osteoarthritis Outcome Score (KOOS) pain score, KOOS function score, and KOOS quality of life (QOL) score. Model accuracies within the imputed data set were assessed through cross-validation with root mean square errors (RMSEs) and mean absolute errors (MAEs) for the LOS and PROMs models, and the index of prediction accuracy (IPA), and area under the curve (AUC) for the readmission models. Model accuracies in new patient data sets were assessed with AUC. RESULTS: Within the imputed datasets, the LOS (RMSE 1.161) and PROMs models (RMSE 15.775, 11.056, 21.680 for KOOS pain, function, and QOL, respectively) demonstrated good accuracy. For all models, the accuracy of predicting outcomes in a new set of patients were consistent with the cross-validation accuracy overall. Upon validation with a new patient dataset, the LOS and readmission models demonstrated high accuracy (71.5% and 65.0%, respectively). Similarly, the one-year PROMs improvement models demonstrated high accuracy in predicting ten-point improvements in KOOS pain (72.1%), function (72.9%), and QOL (70.8%) scores. CONCLUSION: The data-driven models developed in this study offer scalable predictive tools that can accurately estimate the likelihood of improved pain, function, and quality of life one year after knee arthroplasty as well as LOS and 90 day readmission. Cite this article: Bone Joint J 2020;102-B(9):1183-1193.
引用
- Anis HK, Strnad GJ, Klika AK, et al. Developing a personalized outcome prediction tool for knee arthroplasty. Bone Joint J. 2020. PMID: 32862678. doi:10.1302/0301-620X.102B9.BJJ-2019-1642.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。